Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INFUNYSE:INFUNASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINFUInfuSystem$4.94-2.7%$6.61$4.61▼$9.97$103.69M1.980,692 shs62,562 shsINFUInfuSystem$4.94-2.7%$6.61$4.61▼$9.97$103.69M1.980,692 shs62,562 shsTCMDTactile Systems Technology$13.30-2.2%$14.63$11.12▼$21.10$314.88M1.21250,002 shs81,059 shs10 Stocks Set to Soar in Spring 2025Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINFUInfuSystem+5.63%-4.70%-10.11%-35.98%-40.84%INFUInfuSystem+5.63%-4.70%-10.11%-35.98%-40.84%TCMDTactile Systems Technology+4.62%-1.95%-1.31%-22.65%-12.77%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINFUInfuSystem1.3801 of 5 stars2.00.00.00.01.12.51.9INFUInfuSystem1.3801 of 5 stars2.00.00.00.01.12.51.9TCMDTactile Systems Technology3.1024 of 5 stars3.01.00.00.02.82.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINFUInfuSystem 4.00Strong Buy$13.00163.42% UpsideINFUInfuSystem 4.00Strong Buy$13.00163.42% UpsideTCMDTactile Systems Technology 2.00Hold$18.0035.39% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, INFU, and INFU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy2/19/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$23.00 ➝ $18.00(Data available from 4/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINFUInfuSystem$134.86M0.77$0.39 per share12.79$2.47 per share2.00INFUInfuSystem$134.86M0.77$0.39 per share12.79$2.47 per share2.00TCMDTactile Systems Technology$292.98M1.07$0.94 per share14.21$9.18 per share1.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINFUInfuSystem$870K$0.1082.2515.92N/A1.12%2.78%1.41%N/AINFUInfuSystem$870K$0.1082.2515.92N/A1.12%2.78%1.41%N/ATCMDTactile Systems Technology$28.51M$0.7019.0115.83N/A5.79%9.37%6.75%5/5/2025 (Estimated)Latest TCMD, INFU, and INFU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025TCMDTactile Systems Technology-$0.07N/AN/AN/A$63.48 millionN/A2/18/2025Q4 2024TCMDTactile Systems Technology$0.31$0.40+$0.09$0.40$85.39 million$85.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINFUInfuSystemN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINFUInfuSystem0.501.981.59INFUInfuSystem0.501.981.59TCMDTactile Systems Technology0.114.363.80Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINFUInfuSystem71.13%INFUInfuSystem71.13%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipINFUInfuSystem10.20%INFUInfuSystem10.20%TCMDTactile Systems Technology0.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINFUInfuSystem41021.02 million19.10 millionOptionableINFUInfuSystem41021.02 million19.10 millionOptionableTCMDTactile Systems Technology98023.67 million23.36 millionOptionableTCMD, INFU, and INFU HeadlinesRecent News About These CompaniesTactile Systems Technology: Interesting Devices Company, Need More ClarityApril 7 at 1:30 PM | seekingalpha.comIntegrated Quantitative Investments LLC Purchases Shares of 64,125 Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 6, 2025 | marketbeat.comReviewing Modular Medical (NASDAQ:MODD) and Tactile Systems Technology (NASDAQ:TCMD)April 4, 2025 | americanbankingnews.comTactile Systems Technology (NASDAQ:TCMD) Downgraded by StockNews.com to "Buy"March 30, 2025 | marketbeat.comEntryPoint Capital LLC Buys Shares of 19,485 Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 28, 2025 | marketbeat.comSemanteon Capital Management LP Buys New Holdings in Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 23, 2025 | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Rating Increased to Strong-Buy at StockNews.comMarch 22, 2025 | marketbeat.comShort Interest in Tactile Systems Technology, Inc. (NASDAQ:TCMD) Decreases By 16.5%March 19, 2025 | marketbeat.comRoyce & Associates LP Sells 65,917 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 19, 2025 | marketbeat.comThe Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't GrowingMarch 18, 2025 | finance.yahoo.comTactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 5, 2025 | globenewswire.comA Closer Look At Tactile Systems Technology's EarningsFebruary 26, 2025 | finance.yahoo.comElaine M. Birkemeyer Sells 3,778 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) StockFebruary 25, 2025 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Cross Country Healthcare (CCRN)February 24, 2025 | markets.businessinsider.comRSI Alert: Tactile Systems Technology (TCMD) Now OversoldFebruary 24, 2025 | nasdaq.comB. Riley Securities Downgrades Tactile Systems Technology (TCMD)February 19, 2025 | msn.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | msn.comTactile Systems Technology (TCMD) Gets a Hold from BTIGFebruary 19, 2025 | markets.businessinsider.comTactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | seekingalpha.comTactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue EstimatesFebruary 18, 2025 | zacks.comTactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 18, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTCMD, INFU, and INFU Company DescriptionsInfuSystem NYSE:INFU$4.93 -0.14 (-2.66%) As of 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.InfuSystem NYSE:INFU$4.93 -0.14 (-2.66%) As of 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Tactile Systems Technology NASDAQ:TCMD$13.30 -0.30 (-2.17%) As of 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom's Big Outperformance Shows Strength Amid Tariff Decline Delta, Walmart Cut Profit Targets: Could Start Domino Effect Joby Aviation: Operational Momentum vs. Market Sentiment Carvana: Can Turnaround Strength Outdrive Market Headwinds? Is Alphabet a Generational Buying Opportunity at These Levels? Meta Seeks Trump's Help in FTC Trial: The Implications Are Huge Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop? Harley-Davidson Tops Watchlists: Value Trap or Turnaround Play? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
